Funding bodies should foster partnerships between industry and academia.
作者信息
Tzircotis George, Hickson Tony, Foulkes Iain
机构信息
Research & Innovation, Cancer Research UK, London, UK.
出版信息
Nat Rev Cancer. 2021 Feb;21(2):65-66. doi: 10.1038/s41568-020-00326-w.
PMID:33398101
Abstract
摘要
相似文献
1
Funding bodies should foster partnerships between industry and academia.
Nat Rev Cancer. 2021 Feb;21(2):65-66. doi: 10.1038/s41568-020-00326-w.
2
Funders must be wary of industry alliances.
Nature. 2018 Aug;560(7718):283. doi: 10.1038/d41586-018-05937-w.
3
Academia-pharma partnerships for novel drug discovery: essential or nice to have?
Expert Opin Drug Discov. 2017 Jun;12(6):537-540. doi: 10.1080/17460441.2017.1318124. Epub 2017 Apr 17.
4
US advisers seek research overhaul.
Nature. 2012 Dec 6;492(7427):18. doi: 10.1038/492018a.
5
Europe's innovation hub finally KICs off.
Nature. 2011 Feb 24;470(7335):450. doi: 10.1038/470450a.
6
[Development of synergies and partnerships on rare diseases: model of a scientific cooperation foundation].
Presse Med. 2012 May;41 Suppl 1:S23-5. doi: 10.1016/j.lpm.2012.02.029. Epub 2012 Apr 6.
7
Industry links boost research output.
Nature. 2017 Dec 7;552(7683):S11-S13. doi: 10.1038/d41586-017-07422-2.
8
The CNCCS, a benchmark Italian consortium for bioeconomy and an opportunity for the Istituto Superiore di Sanità.
Ann Ist Super Sanita. 2012;48(2):115-6. doi: 10.4415/ANN_12_02_01.
9
Institute doomed by loss of interest in basics.
Nature. 2004 Jul 15;430(6997):282. doi: 10.1038/430282a.
10
Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation.
Clin Pharmacol Ther. 2013 Sep;94(3):314-6. doi: 10.1038/clpt.2013.89. Epub 2013 May 3.
Zotero 插件